0
Intec Pharma Banner Image

Intec Pharma has reached its limit for free report views

Work for Intec Pharma? Upgrade Your Profile and unlock all your annual reports.

Intec Pharma

  • Ticker NTEC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intec Pharma Logo Image
  • 51-200 Employees
  • Based in Jerusalem, Israel
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company'sMore product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is in late-stage Phase 3 development for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, and AP-cannabinoids, an Accordion Pill to deliver either or both of the primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various pain indications. In addition, the Company has a feasibility agreement for the development of a custom-designed Accordion Pill for a proprietary compound with Novartis Pharmaceuticals.
Intec Pharma

Most Recent Annual Report

Intec Pharma MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Intec Pharma has reached its limit for free report views.

Older/Archived Annual Reports